JOYCE ROBY enters BIOAFFINITY TECHNOLOGIES, INC. with 583.13K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 9/26/2023ACC: 0001493152-23-033750
583.13K
Baseline shares
0.00
Direct ownership
0 positions
20K
Derivative underlying
2 instruments
1
Security positions
583.13K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned583.13K
Total
583.13K indirect583.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 583.13K | Indirect |
| Total | 583.13K | 583.13K indirect |
Derivative Holdings2
Warrant
IndirectUnderlying security
Common Stock
Underlying shares
5.71K
Shares owned
N/A
Exercise price
5.25
Expiration
—
Exercise window
—
Warrant
IndirectUnderlying security
Common Stock
Underlying shares
14.29K
Shares owned
N/A
Exercise price
5.25
Expiration
—
Exercise window
—
Total
Underlying
20K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant Indirect | Common Stock | 5.25 | — | — | 5.71K | N/A |
| Warrant Indirect | Common Stock | 5.25 | — | — | 14.29K | N/A |
| Total | 20K | 0.00 | ||||